Latest Metformin Stories
A research team at the Shanghai Jiao Tong University in China has conducted a meta-analysis demonstrating that metformin treatment also appears to be associated with significantly lower risk of
A recent Phase III investigation by has demonstrated that a new medication for the treatment of Type 2 diabetes significantly lowers blood glucose levels in adults while exhibiting few side effects
A recent study that analyzed over 3,400 French adults over a period of 14 years found that those with Type 2 diabetes who received insulin treatment had a significantly increased risk of death
SAN FRANCISCO, Aug. 16, 2011 /PRNewswire/ -- Practice Fusion's Research Division released today the second annual Prescription Index of the 20 most commonly prescribed medications by specialty among physicians using the company's Electronic Medical Record (EMR) system.
CARLSBAD, Calif., July 21, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has initiated a Phase 1 clinical study for ISIS-PTP1BRx, an antisense drug for the treatment of type 2 diabetes targeting protein tyrosine phosphatase-1B, PTP-1B.
- The act of sweetening by admixture of some saccharine substance.